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ABSTRACT 
A  derivative of the hypothalamic peptide luteinizing hormone-releasing hormone 
(LHRH)  has been  coupled to ferritin  and the conjugate purified by gel chroma- 
tography.  In  its  ability  to  stimulate  the  secretion  of luteinizing  hormone  from 
pituitary cells in vitro,  the conjugate has the same potency and specificity as the 
native peptide.  When dissociated pituitary  cells maintained  in short-term  culture 
are  lightly  fixed  with  formaldehyde  and  then  incubated  with  the  conjugate, 
examination  in  the  electron  microscope  shows  an  even  distribution  of ferritin 
particles over the free cell surface of the gonadotrophin cells. This binding appears 
to be specific for the LHRH  receptor since it is prevented by a  10-fold excess of 
native peptide.  In addition  to the  gonadotrophin  cells,  some somatotrophin  and 
thyrotrophin cells bind conjugate on their free surfaces under similar conditions. 
If living cells are incubated with the conjugate for 15 min, the bound conjugate 
becomes  aggregated  and  then  concentrated  in  one  localized  area  of  the  cell 
surface.  In this  area,  which lies  immediately  above the juxtanuclear  Golgi com- 
plex, the plasma membrane is frequently invaginated in a  manner which suggests 
that the bound,  aggregated conjugate is internalized  by endocytosis. 
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Studies  on  the  interaction  between  peptide  and 
polypeptide hormones and their cell surface recep- 
tors have indicated the quantitative  nature of the 
interaction in several systems (4, 5, 13). The topo- 
graphical  distribution  of hormone receptors has, 
however,  been  less  well  studied,  and  little  is 
known of the spatial relationships and redistribu- 
tive events which may occur as a consequence of a 
hormone binding to its surface receptor. Studies of 
the effects of multivalent ligands on the redistribu- 
tion of lymphocyte plasma membrane components 
serve to illustrate the plasticity of cell surface pro- 
teins  (19.  23),  while  an  increasing  number  of 
reports suggest that the availability  and the location 
of hormone receptors  may be subject  to a  rapid 
and profound change primarily as a result of the 
receptor population binding hormone (4,  9,  11). 
Approaches employing hormone probes which are 
both  biologically  active  and  identifiable  with  a 
microscope are available (17), and these allow this 
question  to  be  examined  directly.  In  the  work 
reported here, we have developed an analogue of 
the  hypothalamic  peptide  hormone  luteinizing 
hormone-releasing hormone (LHRH) as a labeled 
probe. This hormone is a specific secretagogue for 
gonadotrophin secretion  in  the anterior  pituitary 
(21), and we have modified it for use in conjunc- 
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specific receptor sites on the cell surface.  We have 
established that the LHRH receptors are predomi- 
nantly,  and  probably  exclusively, located  on  the 
pituitary  cell surface  and  demonstrated  that,  be- 
fore  their  interaction  with  the  peptide,  these  re- 
ceptors are evenly distributed over the surfaces of 
the gonadotrophin  cells. We have also found that 
when conjugate is applied to living cells, a redistri- 
bution of the binding sites occurs so that the even 
distribution  observed  in  fixed cells is replaced by 
an  aggregation  and  preferential  concentration  at 
one pole of the cell. At this pole the concentrated 
conjugate is apparently lost both by sloughing into 
the surrounding  medium  and  by endocytosis into 
the ceil. 
MATERIALS  AND  METHODS 
Poly-L-lysine (type II mol wt 1,000-4,000) was obtained 
from  Sigma  (London)  Chemical  Co.,  Kingston-upon- 
Thames, U. K. Culture media were obtained from Gibco 
Bio-cult Ltd., Paisley, U. K.; ferritin from Miles Labora- 
tories, Slough, U. K.; Biogel A-5M and  P2 from Bio- 
Rad Laboratories, St. Albans, Herts, U. K.; and hemo- 
cyanin  (keyhole limpet) from Calbiocbem Ltd.,  Here- 
ford, U. K. ~zsI (carrier-free 100 mCi/ml) was obtained 
from the Radiochemical Centre, Amersham, U. K. All 
other reagents were of the highest analytical grade ob- 
tainable. 
The competitive inhibitor des histidine z (des-his 2) D- 
alanine  6 (o-ala  6) LHRH proethylamide was kindly pro- 
vided by Dr. Roger Guillemin (Salk Institute, La JoUa, 
Calif.). 
Methods 
PREPARATION  OF  t0 -GLUTAMIC  ACID-HISTI- 
DIN  E - TRYPTO  PHA  N  -  SERI  N E  - TYROSI  N E  -  D-  HS -  LY - 
SINE-ARGININE  ETHYLAMIDE: The  peptide  used 
in the present work was prepared  by step-wise elonga- 
tion  from  L-proline  ethylamide  to  give  the  penta- 
peptide  Z-tyrosine(But)-I>-lysine(Boc)-ieucine-arginine  - 
proethylamide?  The  benzyloxycarbonyi group  was  re- 
moved by  hydrogenolysis  and  the  dipeptide  azide  Z- 
tryptophan-serine  N3  added  to  give  a  heptapeptide. 
After hydrogenation the dipeptide p-glutamic acid-histi- 
dine N~ was added in a similar manner and the protected 
nonapeptide  purified  by chromatography  upon  Sepha- 
dex LH-20. The two side chain  protecting groups were 
removed from  tyrosine  and  lysine  by  treatment  with 
trifluoracetic acid-water (9:1).  Purification by partition 
chromatography on Sephadex G-25 with an n-butanol- 
Abbreviations used in this paper:  Boc, t-butyloxycar- 
bonyl; Bu  t, t-butyl; HS, hemisuccinate; and Z, benzylox- 
ycarbonyl. 
acetic acid-pyridine  water system (5:1:1:5) was followed 
by gel chromatography on Sephadex G-25 in 1 M acetic 
acid. The product was homogeneous as judged by paper 
electrophoresis  at  pH  2.1,  6.5,  or  8.9,  by  thin-layer 
chromatography on silica plates in n-butanol-acetic acid- 
water (4:1:5) and by amino-acid analysis. 
Preparation of the hemisuccinate of the nonapeptide 
was carried out in anhydrous pyridine with a threefold 
excess of 1:4 14C succinic anhydride at 4~  Formation of 
the hemisuccinate derivative of the epsilon amino group 
of the iysine residue was followed by paper electrophore- 
sis at pH 6.5 until only the less basic radioactive product 
was observed. This was isolated by gel chromatography 
upon Sephadex (3-25 in  1 M acetic acid. 
COUPLING  THE  LHRH  PEPTIDE  TO  FERRI- 
TIN:  Fcrritin  (6  x  crystallized,  cadmium-free)  was 
further purified by recrystallization  according to Breese 
and Hsu (3). Conjugation of the peptide (0.16/~M) to 
the purified ferritin  (0.014  g.M) was  carried out using 
10-fold  excess  1-ethyl-3-(3-dimethyl-amino-propyl)car- 
bodiimide in  1 ml of H20 at 4~  for 3-4  days.  After 
conjugation, the reaction mixture was applied to 30  x 
2.5  cm  column  of Biogel A-5M in  0.4  M  phosphate 
buffer pH 7.2. The proportion of ferritin to peptide was 
indicated  by the spectrophotometric estimation (A310) 
of ferritin  and  radioimmunoassay  of the  peptide  (de- 
tailed below). In the total conjugate there was  a  10% 
incorporation of peptide. In the pooled fractions used in 
the experiments described, the ratio of peptide to ferritin 
was  1:1.  For use with cells,  the conjugate was  diluted 
initially with double-strength culture medium and there- 
after accordingly in single-strength  medium. 
CELL  DISSOCIATION:  Pituitaries from male, 200 
g Spraguc-Dawley rats were removed and dissociated  by 
the method of Hymer et al.  (16).  The cell suspension 
produced was freed from fine cell debris by centrifuga- 
tion through 4% bovine serum albumin, resuspended in 
Dulbecco's modified Eagle's essential medium (DMEM) 
containing  10% fetal calf serum and plated out in aliquots 
of 4  x  106 cells in 2.5-cm diameter petri dishes  coated 
with poly-L-lysinr (14). The cells were incubated for 48 h 
at  37~  for  them  to  become  optimally responsive  to 
LHRH stimulation (14) and were then rinsed three times 
in DMEM containing 0.1% gelatin (DMEM/gel) before 
being fixed or treated with conjugate as described below. 
For bioassay, 48-h-incubated cells were similarly  rinsed 
in DMEM/gel before being incubated for 1 h within 1 ml 
DMEM/gel (control) with additions as indicated in the 
appropriate legend. Dishes were used in  triplicate and 
after the 1-h incubation the media were connected, cen- 
trifuged for 15 min at 3,000 g and then freeze-stored at 
-20~  until assay. 
RADIO1MMUNOASSAY:  LH  was  assayed  by  the 
N.I.A.M.D.D.  homologous  double  antibody  radioim- 
munoassay  (22). N.I.A.M.D.D. rat LH-RP-1 was used 
as  standard  and  goat  antirabbit  Fabx as  precipitating 
antibody.  The  assay  had  a  sensitivity  of 2.65  •  0.34 
(SD) ng N.I.A.M.D.D. rat LH RP-1. 
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noassayed by using a protocol similar to that employed 
for  LH  and employing an  antiserum raised  in rabbit 
against  a D-Iys  6 LHRH hemisuccinate-hemocyanin  con- 
jugate prepared in the same manner as the D-Iys  6 LHRH- 
ferritin conjugate. Iodinated antigen was prepared by the 
method of Greenwood et al. (10) modified  so that the 
chloramine-T oxidation step was extended to 15 s. Free 
nM was removed by gel chromatography on Biogel Pz- 
The assay has a sensitivity of 1 ng/ml. Displacement of 
[l~M]lys6 LHRH by ~lys  6 LHRH and the o-lys  6 LHRH- 
ferritin conjugate produced identical curves, and it was 
therefore concluded that the free and conjugated pep- 
tides were immunologically similar. 
INCUBATION  WITH  CONJUGATE  AND  FIXA- 
TION  FOR  ELECTRON  MICROSCOPY:  Several  kinds 
of  fixation  protocol  were  employed.  In  procedures 
in which living cells were incubated with conjugate, the 
incubation was followed by five 1-min rinses in DMEM/ 
gel at  5~  and then f'Lxation in Karnovsky fluid  (18) 
diluted  1:1  with  DMEM/gel.  Alternatively, cells  pre- 
fixed for 2 min in 0.1% formaldehyde in 0.1 M cacodyl- 
ate buffer at pH 7.2 were used. These prefixed cells were 
then rinsed 3 x  2 min in PBS containing 1 Izg/ml gelatin 
and 0.25  tzg/ml borohydride to remove and inactivate 
unreacted aldehyde  (20).  Thereafter,  they were  incu- 
bated with conjugate, rinsed in DMEM/gel at 5~  and 
fLxed in Karnovsky fluid diluted with DMEM/gel as for 
living cells. 
Fixed cells were all finally scraped  from the dish sur- 
face with a polythene policeman and processed  as de- 
scribed  by  Hopkins  and  Farquhar  (15).  In  order  to 
increase the contrast of the ferritin, ultrathin sections 
were  stained on the grid  according  to  the method of 
Ainsworth and Karnovsky (1). 
RESULTS 
Fig.  1 shows the profile obtained when the ~lys  6 
hemisuccinate conjugated to ferritin as described 
in Materials and Methods is chromatographed on 
Biogel A5M in 0.4 M phosphate buffer. Aliquots 
taken for bioassay and immunoassay indicate that 
bioreactive and immunoactive peptide  is present 
in  the  two  peaks  containing ferritin  and  in  the 
peak corresponding to free o-lys  6 LHRH hemisuc- 
cinate used as standard.  Rechromatographing of 
fractions 75-80 which were subsequently used for 
binding studies  showed  no  biological activity  or 
immunoreactivity in the position expected for free 
peptide (Fig.  1B). 
Microscope  examination of  material from  the 
first peak containing ferritin (fractions 35-40) by 
negative staining showed varying degrees of gross 
aggregation  in  the  ferritin.  In  fractions  75-80, 
most of the ferritin micelles were clearly separated 
and monomeric. The dose response curve derived 
using the ferritin conjugate from fractions 75-80 
shows  that,  in terms  of its ability to  induce LH 
release from dissociated cells, the conjugate has a 
biological activity equal to  that  of o-lys  6 LHRH 
and to that of the native peptide (Fig. 2). The half- 
maximal dose levels and the threshold dose levels 
are the same for peptides and conjugate at 2.5  ￿ 
10  -s M  and 10  -7 M, respectively. To explore the 
possibility that the observed biological activity of 
the conjugate was due to free peptide dissociated 
from  the  conjugate  during the  bioassay  incuba- 
tion, 1 ml of conjugate was incubated for 6 h with 
8  ￿  106 cells and then collected and rechromato- 
graphed on Biogel A-5M. Radioimmunoassay for 
~lys  ~ LHRH  in the  eluent showed  that  most  of 
the peptide immunoradioactivity remained associ- 
ated with the conjugate, 
The specificity of the conjugate indicated by its 
ability to  displace radiolabeled peptide  from  the 
dissociated cells will be the subject of a later publi- 
cation. As shown in Fig. 3, however, the specific- 
ity of the ferritin-peptide conjugate for the LHRH 
receptor can be demonstrated by the influence of 
the  des-His  2  o-ala  6  proethylamide  LHRH  ana- 
logue on the  LH releasing activity of the  conju- 
gate. This competitive inhibitor of LHRH  (6.25) 
has  the  same  effect,  at  the  same  dose  level,  on 
conjugate as it does on the native peptide. 
Topographical Localization 
Initially, dissociated  cells  incubated  for  48  h 
postdissociation  were  used  without  prefixation. 
The  cells  were  rinsed  free  of  serum  with  three 
changes of  DMEM/gel  and then  incubated with 
conjugate for 15 min at 20~  The conjugate was 
used  at  a  concentration  equivalent  to  10  -7  M 
LHRH  (as  determined by  its  immunoreactivity) 
and was included in DMEM/gel. At the end of this 
incubation, the cells were given five  1-min rinses 
with DMEM/gel at  5~  in order to remove free, 
unbound conjugate and then fixed in dilute Kar- 
novsky fluid for 15 min and processed for electron 
microscopy as described in  Materials and  Meth- 
ods. 
In preparations derived by using this protocol, 
the  conjugate associated  with the  cells occurs  as 
coarse aggregates and is usually preferentially lo- 
calized in one area of the cell surface (Figs. 4 and 
5).  The  aggregates  are  associated  not  only with 
gonadotrophin cells but also with other secretory 
cell types, most notably somatotrophin and thyro- 
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FIOURE  I  (A)  OD profile (A--A)  obtained by chromatographing ferritin-peptide conjugate on a 30 ￿ 
2.5-cm column of Biogel A-5M in 0.4 M phosphate buffer. As indicated (A) each fraction was bioassayed 
for LH-releasing activity.  Activity was present in the two main ferritin peaks and in the position of free 
peptide (in fractions 100-115+). (B)  Profile obtained when fractions of the eluent shown in Fig. 1 A were 
tested for imrnunoreactivity using antiserum raised against a o-lys  e LHRH HS-hemocyanin conjugate. The 
distribution of the peptide as shown by immunoreactivity (O--O) is the same as that shown by bioassay. 
Also shown is the immunoreactive profile (0- - -0) obtained when an aliquot of pooled fractions 75-80 is 
rechromatographed. In this profile, there is no immunoreactivity in fractions  100-120, indicating that the 
conjugate in fractions 75-80 contains negligible  free peptide. 
trophin  cells.  2 Occasionally,  the  accumulation  of 
aggregates  is  very  dense,  and  the  surface  layers 
2 In Figs. 4-11, identification  of the various cell types is 
based primarily on the size of the secretory granules. The 
basis of this identification has been documented in detail 
elsewhere (8,  15). 
appear to be about to slough away. Free clumps of 
aggregate  are occasionally seen  in these  prepara- 
tions. 
In  the  area  in  which  aggregated  conjugate  be- 
comes concentrated, the plasma membrane is fre- 
quently  invaginated.  These  invaginations  always 
include aggregated conjugate,  and below them in 
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FIGURE 2  Dose response curve showing the  LH-re- 
leasing activity of the LHRH native peptide (G--G), the 
o-lys  8 (O--II) and D-Iys6-HS  analogues (A--A) and the 
D-lys  8 HS-ferritin conjugate (A--A). All of these pep- 
tides and peptide derivatives  have the same half-maximal 
(2  x  10  -8 M) and maximal response (-10  -7 M). The 
dissociated cells used in this bioassay were incubated for 
48 h before being rinsed free of serum. Dishes in tripli- 
cate were then incubated for 1 h with either the peptide 
or peptide conjugates. Basal LH release 50 •  6.4 ng/10  s 
cells. Variation bars show the total SEM of all of the 
samples at any given peptide concentration. 
the  juxtanuclear Golgi area  lysosome-like struc- 
tures  packed  with  conjugate  are  often  present 
(Fig.  5).  In these  preparations, intracellular de- 
posits of ferritin aggregates were also observed in 
the nonsecretory follicular cells (8). These aggre- 
gates were always contained within lysosome-like 
bodies and no binding of individual ferritin mi- 
celles to the surfaces of these cells was apparent. 
In preparations preincubated for  30  rain with 
10 -6 M LHRH and in which the conjugate incuba- 
tion also included 10 -6 LHRH, coarse aggregates 
are absent although particulate ferritin does occur 
both within the  intercellular spaces between ag- 
gregated cells and on the free cell surface where 
there  are  minor irregularities such  as  microvilli 
(Figs. 6 and 7). 
From these observations it was concluded that 
the coarse aggregation of the ferritin conjugates is 
probably caused by a  redistribution of conjugate 
after it has bound to the cell surface. Preliminary 
observations in which the incubation with conju- 
gate was carried out at 5~  showed little evidence 
of aggregation. As an alternative approach and in 
order to examine the possibility that a redistribu- 
tion  of  the  LHRH  receptors  is  induced by  the 
binding of the ferritin conjugate, we lightly pre- 
fixed the  cells  with formaldehyde before  adding 
the conjugate. Thus, cells attached to dishes and 
incubated for 48 h  were rinsed three times with 
serum-free medium and fixed for 2 min in 0.1% 
formaldehyde in cacodylate buffer (pH  7.4). To 
remove  and  inactivate unreacted  aldehyde,  the 
cells were then rinsed 3 x  2 min in PBS containing 
1 /zg/ml  gelatin and 0.25  /zg/ml  sodium borohy- 
dride  (20). Thereafter, the cells were  treated as 
before,  the  control pretreatment and incubation 
with  10 -6  M  LHRH  being carried  out  on  the 
prefixed cells. 
The distribution of ferritin-LHRH conjugate on 
prefixed cells is illustrated in Figs. 8-11. The ferri- 
tin probe is distributed over the entire free surface 
of  all  gonadotrophin cells.  Binding is  also  ob- 
served on the free surfaces of some somatotrophin 
and thyrotrophin cells. In these preparations there 
is little evidence of conjugate aggregation, and, 
where  groups  of  two  to  three  ferritin  micelles 
occur on the cell surface, it is likely that they are 
derived from  the  minority population of  aggre- 
gates seen in negatively stained preparations of the 
conjugate.  To  estimate  the  number of  binding 
sites, we have scored groups of two or more ferri- 
tin miceUes as one and counted the number bound 
per micromolar of free surface in a random selec- 
tion of gonadotrophin cells. By assuming that  a 
gonadotrophin cell  is  a  sphere  with  an  average 
diameter (D)  of  13  /~m  (---1.4)  and an average 
section thickness of 0.7  /zm, we  have taken the 
area of a sphere as 27rD  e and estimated the num- 
ber of sites over the entire cell surface accordingly. 
The number of micelles bound/square microme/~r 
of membrane in gonadotrophin cells is 32  -  12, 
giving an overall estimate of -30  x  104 per cell. 
In thyrotrophin and somatotrophic cells, the num- 
bers are extremely variable, and we have observed 
cells  with  populations of  micelles  as  dense  as 
3,000  and 2,800 per  /zm  2, respectively. Binding 
of conjugate to follicular cells was not observed in 
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Effect of de,his  2 ~ala  6 LHRH proethylamide on the ability of the native LHRH peptide and 
the ~lys  6 LHRH-ferritin conjugate to release LH. Dissociated cells were plated out at 4 x  10  e per dish, 
incubated for 48 h, rinsed free of serum and incubated in triplicate for 1 h as indicated. Variation bars 
indicate • 
prefixed preparations. In control preparations of 
prefixed cells preincubated with  10  -e M  LHRH, 
the distribution of ferritin conjugate is in all re- 
spects the same as that observed with unfixed cells 
that have similarly been preincubated with native 
peptide (Figs. 6 and 7). 
To examine the possibility that the distribution 
of cell surface components may be altered in cells 
plated out on plasma-coated dishes, cells initially 
aliquoted onto uncoated dishes were also exam- 
ined. In these preparations after a 48-h incubation 
fewer  cells  survive the  initial rinsing procedure 
and, because there is considerable reaggregation, 
the amount of free surface available for examina- 
tion is much reduced. Nevertheless, in cells from 
these preparations prefixed with 0.1% formalde- 
hyde, the bound conjugate has an even distribu- 
tion similar to that shown in Figs. 8 and 9. 
DISCUSSION:  The ability of the  D-lys  6 ana- 
logue  of  LHRH  to  retain  its  biological activity 
when it is conjugated to a macromolecular compo- 
nent via  the  epsilon  amino group  of the  D-lys  6 
residue was initially shown by the studies of Amos 
et al. (2). These workers found that when conju- 
gated  to  polyglutamic  acid  (average  mol  wt, 
100,000)  this  peptide  possessed  significant LH- 
releasing activity in vivo. Our studies with ~lys  6 
LHRH proethylamide conjugated to ferritin are in 
agreement with this finding, although for a reason 
that  as  yet  remains unclear we  were  unable to 
conjugate the peptide to the ferritin directly and 
an extended linkage provided by the succinylation 
of the amino group was therefore used. The po- 
tency of this ferritin conjugate together with the 
shape of its dose-response curve and relative de- 
gree of inhibition induced by the competitive in- 
hibitor des-His  2 D-ala  6 LHRH proethylamide (6, 
25) all serve to demonstrate that the D-lys  6 LHRH 
conjugate is interacting with the pituitary cells in a 
manner similar to that of the native peptide. 
The  difference in molecular size  between the 
conjugate and the peptide allows the conjugate to 
be readily separated from the unconjugated pep- 
tide by gel chromatography, and it is thus most 
unlikely that any of the biological activity demon- 
strable with the fractionated conjugate can be at- 
tributed to contaminating  peptide. In this context, 
it is worth noting that the potency of the conjugate 
and the nature of its interaction with the gonado- 
trophin cells as shown by bioassay provides strong 
HOPKINS AND  GREGORY  Localization of LHRH Receptors on Dissociated Pituitary Cells  533 FIGURE  4  Periphery of a gonadotrophin cell incubated unfixed for 15 min with peptide-ferritin conju- 
gate. The conjugate is aggregated into small focal concentrations. Invagination  of the plasma membrane 
occurs immediately above the Golgi area.  x  70,000. 
F1GURE  5  Periphery of a thyrotrophin cell incubated unfixed for 15 min with peptide-ferritin conjugate. 
The aggregated conjugate forms a thick, fragmentary cap in this area while the plasma membrane forms 
deep invaginations  containing conjugate.  ￿  55,000. The inset shows lysosome-like  structures containing 
conjugate; these were often observed in the vicinity of the Golgi complex in these preparations. ￿  23,500. FIguRes  6-7  Preparation incubated unfixed (15 min) with peptide-ferritin conjugate in the presence of 
10 -6 M  LHRH after a 30-min preincubation with 10 -~ M  LHRH. Conjugate is confined to intercellular 
areas within aggregates (Fig. 6) and to surface irregularities such as folds and microvilli (Fig. 7). In these 
control preparations, ferritin particles are rarely found on the free surface. Fig. 6,  ￿  60,000.  Fig. 7,  ￿ 
65,000. 
HOPKINS ANt) GREC,  ORY  Localization of LHRH Receptors on Dissociated Pituitary Cells  535 FIGURES 8-9  Periphery of gonadotrophin cells prefixed in 0.1% formaldehyde before being incubated 
with the peptide-ferritin conjugate. The ferritin micelles  are evenly distributed along the surface of the 
plasma membrane. The  arrow  indicates a  vesicle-like  structure containing ferritin; these profiles are 
uncommon; and  since the  cells  are  prefLxed, they  presumably represent indentations of the  plasma 
membrane confluent with the extracellular space. Both electron micrographs, x  80,000. FIGURE 10  Periphery of a somatotrophin cell prefixed before being incubated with the peptide-ferritin 
conjugate.  Small  clusters of ferritin  micelles  (probably  reflecting some  aggregation  in  this conjugate 
preparation) are distributed at intervals along the cell surface,  x  85,000. 
Fmut~  11  Periphery of a  thyrotrophin cell prefixed before being incubated with the conjugate,  and 
demonstrating the densest population of binding sites observed in this cell type.  x  70,000. evidence for the exclusive location of LHRH re- 
ceptors on the extracellular surface of the plasma 
membrane at a site which is directly accessible to 
this  large  (500,000  mol  wt)  macromoiecular 
probe. The suggestion that an additional primary 
site  of LHRH  action  may  have  an  intracellular 
location (24) is thus not supported by our data. In 
purifying the conjugate by gel chromatography, it 
has  not  been  possible to  remove,  entirely, free 
ferritin from the peptide-ferritin conjugate. How- 
ever, the absence of conjugate on the free surface 
of prefixed cells incubated in the presence of a 10- 
fold excess of free peptide serves to demonstrate 
that in this system the nonspecific binding by both 
free ferritin and ferritin conjugate is negligible. 
From the foregoing considerations, we conclude 
that the binding of ferritin conjugate observed on 
the free cell surfaces of prefixed preparations di- 
rectly demonstrates the distribution of LHRH re- 
ceptor  sites on  these  cells.  With the  use  of the 
conjugate with prefixed cells, it is clear that these 
receptor sites have a rather even distribution over 
the gonadotrophin cell surface. The effect of pre- 
fixation with  aldehyde on  the binding of LHRH 
has not been quantitatively evaluated, and thus for 
the time being any precise assessment of the num- 
ber of receptors on each gonadotrophin cell must 
be  tentative.  Unfortunately,  until  a  pure  or en- 
riched preparation of gonadotrophin cells is avail- 
able a  meaningful estimate of the number of re- 
ceptor  sites  per  gonadotrophin  cell  cannot  be 
made by the usual averaging methods of quantita- 
tive binding assay. It is of interest to note, how- 
ever, that the number of receptors on each gonad- 
otrophin cell estimated in the present study is of 
the same order of magnitude as that reported for 
other peptide and polypeptide hormone receptors 
in other experimental systems (13). 
The  functional  significance  of  the  conjugate 
binding to  secretory cells other than  gonadotro- 
phin cells is unclear. There is evidence from stud- 
ies  on  thyrotrophin-releasing-hormone  (TRH) 
that hypothalamic peptides may indeed have more 
than  one type of target cell in the anterior pitui- 
tary, but for TRH there is also good physiological 
evidence that  the peptide regulates the secretion 
of  more  than  one  kind  of  secretory  cel]  (12). 
LHRH  has  not  been  similarly implicated in  the 
regulation of either somatotrophin or thyrotrophin 
secretion.  The  binding  of LHRH  to  cells other 
than gonadotrophin cells may, of course, be quali- 
tatively different, and it may be that in this loca- 
tion  the  peptide  has  a  developmental  influence 
rather than  any direct, acute affect on  secretory 
product release. 
The  binding of conjugate to  the  nonsecretory 
follicular cells observed in the postfixed prepara- 
tions probably reflects the function of these cells as 
active  phagocytes  (8),  and  it  is  unlikely  to  be 
related to a  specific LHRH-ceU surface receptor 
interaction. This view is supported by the observa- 
tion  that  in  prefixed  preparations  the  follicular 
cells did not bind conjugate on their free surface. 
There is accumulating evidence to suggest that a 
prolonged hormone receptor interaction induces a 
redistribution  and  an  eventual  reduction  in  the 
receptor population specific for the hormone em- 
ployed.  Direct  quantitative  evidence in  favor of 
this  interpretation  has  been  obtained  in  several 
systems (4, 9, 11), but for LHRH in particular the 
evidence remains circumstantial since it has thus 
far only been shown that a short-term exposure is 
sufficient  to  cause  dissociated anterior  pituitary 
cells to become  refractory to  further stimulation 
by the peptide (14). 
The only direct information presently available 
on  the  spatial  distribution  of  peptide  hormone 
receptors  comes  from  the  recent  study  on  the 
binding  of  ct-melanocyte-stimulating  hormone 
(MSH)  to  mouse  melanoma  cells  (7,  26,  27). 
These studies indicate that the MSH receptor sites 
are initially distributed at one pole of the cell over 
the Golgi area and, although prefixation was not 
employed, since binding  was  carried out  at  low 
temperature, it seems unlikely that any redistribu- 
tion of receptor site had occurred. In gonadotro- 
phin cells, an aggregation and polar concentration 
of LHRH  receptors clearly can  occur,  and  it  is 
perhaps worth noting that this redistribution takes 
place without any experimental interference with 
the  subplasma-membrane organization of micro- 
tubules  and  microfilaments.  Nevertheless,  it  re- 
mains to  be  established that  these  redistributive 
processes  represent  a  normal  consequence  of 
LHRH binding to its receptors since a ligand bear- 
ing  more  than  one  binding  site  would  also  be 
expected to cross-link and aggregate receptor sites 
in a  manner analogous to that observed in other 
cells  treated  with  multivalent  ligands  (19,  23). 
With the peptide-ferritin probe used in the present 
study,  one  cannot  exclude  the  possibility that  a 
proportion  of  ferritin  micelles in  the  conjugate 
bear  more  than  one  peptide.  Studies  intent  on 
examining  this  aspect,  using  preparations  pre- 
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are prefixed before the addition of the conjugate, 
are in progress. 
Studies  with  fluorescein-labeled  or  radio-la- 
beled  hormone  probes  are  unlikely  to  allow any 
cross linkage between receptors.  However, in the 
studies  with fluorescein-labeled  a-MSH  (7)  and, 
more  recently,  in  those  in  which  the  binding  of 
~2SI-epidermal growth factor to human  fibroblasts 
has  been  followed (4),  the evidence nevertheless 
suggests  that  receptors bearing hormone  become 
internalized  within  hours  of  the  binding  taking 
place. The functional significance of this process is 
unclear, but it has been suggested that internaliza- 
tion of the receptor-hormone  complex may serve 
to  introduce  the  complex  into  the  intracellular 
location at which its primary influence is directed. 
The  profiles  observed  in  the  present  study  also 
indicate that receptor-bound  LHRH can be inter- 
nalized  and  transported  into  lysosome-like struc- 
tures  in  the  Golgi  area.  However,  should  this 
process  of  internalization  in  the  gonadotrophin 
cell prove to be the normal consequence of LHRH 
binding, any consideration of its functional signifi- 
cance will have to be related to the knowledge that 
the  most  significant  early  consequence  (within  1 
min) of LHRH  stimulation  is LH release by exo- 
cytosis  (14),  a  plasma  membrane-related  event 
which probably occurs over the entire cell surface. 
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